Mergers and acquisitions in the cannabis industry in 2024 totaled $1.169 billion, a decrease of $579 million – or 33% – from the $1.749 billion of industry M&A the previous year, according to Viridian ...

AlphaQuest LLC increased its stake in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 119.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 2,795 shares of ...

This theory "justifies" Pikachu's presence in the Viridian Forest in the early Pokémon games by a terrible real-world ...

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing ...

Viridian designed VRDN-003 to be an infrequent, at-home, and self-administered subcutaneous injection using a low-volume autoinjector. REVEAL-1 and REVEAL-2 Progressing as Planned: Patient ...

Ahead of the 2025 federal budget on Tuesday, a poll has found that clients are concerned about how the budget will impact ...

Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $1.05. This compares to loss of $1.35 per share a year ago.

Arguably the worst way to play a game is via a Twitch chat comments, which was popularized by Twitch Plays Pokemon. But now ...

February 27, 2025--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for ...